Financials Haoxi Health Technology Limited

Equities

HAO

KYG4290F1000

Advertising & Marketing

Market Closed - Nasdaq 16:30:00 2024-05-22 EDT 5-day change 1st Jan Change
6.258 USD -2.07% Intraday chart for Haoxi Health Technology Limited -18.52% 0.00%

Income Statement Evolution (Annual data)

Fiscal Period: June 2021 2022 2023
Net sales 1 12.85 16.16 28.23
EBITDA 1 0.331 0.271 1.204
EBIT 1 0.3306 0.2688 1.196
Operating Margin 2.57% 1.66% 4.24%
Earnings before Tax (EBT) 1 0.3253 0.2596 1.19
Net income 1 0.3041 0.2446 0.9698
Net margin 2.37% 1.51% 3.44%
EPS 2 0.0122 0.009783 0.0351
Free Cash Flow - -0.3381 -1.235
FCF margin - -2.09% -4.37%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 2/15/23 2/15/23 10/24/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2021 2022 2023
Net Debt 1 0.15 0.1 -
Net Cash position 1 - - 0.31
Leverage (Debt/EBITDA) 0.466 x 0.3517 x -
Free Cash Flow - -0.34 -1.23
ROE (net income / shareholders' equity) - -14.4% 1,924%
ROA (Net income/ Total Assets) - 10% 29.9%
Assets 1 - 2.444 3.249
Book Value Per Share 2 -0.0800 -0.0600 0.0500
Cash Flow per Share 2 0 0.0100 0.0400
Capex 1 0 0.01 0.05
Capex / Sales 0.03% 0.05% 0.16%
Announcement Date 2/15/23 2/15/23 10/24/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. HAO Stock
  4. Financials Haoxi Health Technology Limited